Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab Retreatment and Maintenance in CLL
NCT00802737Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by GSK. Started Jan 2009; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00802737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802737.